From NEXT to NICE: From Nanoparticles-based Ex vivo Therapeutics to Nanoparticles-based In vivo Cell Engineering
Time: 3:30 pm
day: Day 1
Details:
• Hybrid/polymeric nanoparticles as a solution to improve CAR T-cell manufacturing process and CAR T-cell product attributes.
• Key performance criteria for an ideal in vivo CAR re-infusable product
• Translational hurdles from ex vivo to in vivo CARs
